Melphalan Supplier-Buyer Network — Trade Flow Analysis

Name: Melphalan Supplier-Buyer Trade Network Dataset — 153+ Indian Exporters, 16+ Importers, 97+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Melphalan supplier network, Melphalan buyers, pharmaceutical export India, Melphalan trade data

TransData Nexus

Melphalan

India Pharmaceutical Trade Intelligence

$12.8M153 Suppliers97 CountriesHS 30049049

ExportsIndia → RUSSIA23.4%India → UNITED KINGDOM21.3%

ImportsUNITED STATES → India$43.2K CANADA → India$38.8K

#1 Supplier: EMCURE PHARMACEUTICALS

Who Supplies Melphalan? Top Manufacturers & Buyers 2026 — EMCURE PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1EMCURE PHARMACEUTICALS LIMITED

EMCURE PHARMACEUTICALS LIMITED is the first-largest Melphalan exporter from India, with a market share of 28.9% and a total export value of $3.7M across 221 shipments. Their average shipment value of $16.7K is above the market average of $15.2K, suggesting premium or bulk contract pricing.

EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TILLOMED LABORATORIES LTD ,,, — $1.1M across 66 shipments (30.0% of this supplier's total exports)

• TILLOMED LABORATORIES LTD ,,, — $987.5K across 59 shipments (26.8% of this supplier's total exports)

• TILLOMED MALTA LTD — $735.4K across 44 shipments (20.0% of this supplier's total exports)

• ACE PHARMA CO. LTD. — $566.4K across 34 shipments (15.4% of this supplier's total exports)

• TILLOMED MALTA LIMITED — $289.4K across 17 shipments (7.9% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LIMITED's per-shipment value of $16.7K is 10% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Melphalan exporter from India, with a market share of 8.0% and a total export value of $1.0M across 22 shipments. Their average shipment value of $46.5K is above the market average of $15.2K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $436.9K across 9 shipments (42.7% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $216.3K across 5 shipments (21.1% of this supplier's total exports)

• TARO PHARMACEUTICALS INC. — $193.5K across 4 shipments (18.9% of this supplier's total exports)

• TARO PHARMACEUTICALS INC. — $176.6K across 4 shipments (17.3% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $46.5K is 206% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.

3GLAND PHARMA LIMITED

GLAND PHARMA LIMITED is the third-largest Melphalan exporter from India, with a market share of 4.2% and a total export value of $539.6K across 3 shipments. Their average shipment value of $179.9K is above the market average of $15.2K, suggesting premium or bulk contract pricing.

GLAND PHARMA LIMITED serves 3 named buyers in our database. Chris Lessly is the dominant customer, accounting for 88.8% of this supplier's tracked business. Top customers include:

• Chris Lessly — $479.3K across 3 shipments (88.8% of this supplier's total exports)

• XXyazXXiomXXicaXXve — $49.1K across 0 shipments (9.1% of this supplier's total exports)

• XXyazXXiomXXikaXXve — $11.2K across 0 shipments (2.1% of this supplier's total exports)

Key Insight: GLAND PHARMA LIMITED's per-shipment value of $179.9K is 1082% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.

4EMCURE PHARMACEUTICALS LTD

EMCURE PHARMACEUTICALS LTD is the fourth-largest Melphalan exporter from India, with a market share of 3.5% and a total export value of $441.3K across 15 shipments. Their average shipment value of $29.4K is above the market average of $15.2K, suggesting premium or bulk contract pricing.

EMCURE PHARMACEUTICALS LTD serves 5 named buyers in our database. TILLOMED LABORATORIES LTD ,,, is the dominant customer, accounting for 61.4% of this supplier's tracked business. Top customers include:

• TILLOMED LABORATORIES LTD ,,, — $271.1K across 9 shipments (61.4% of this supplier's total exports)

• MARCAN PHARMACEUTICALS INC — $125.4K across 4 shipments (28.4% of this supplier's total exports)

• ARABIAN HEALTH CARE SUPPLY CO. — $22.4K across 1 shipments (5.1% of this supplier's total exports)

• EMCURE PHARMA PERU S — $11.2K across 0 shipments (2.5% of this supplier's total exports)

• EMCURE PHARMA CHILE — $11.2K across 0 shipments (2.5% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LTD's per-shipment value of $29.4K is 93% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.

5INVEX HEALTH PRIVATE LIMITED

INVEX HEALTH PRIVATE LIMITED is the fifth-largest Melphalan exporter from India, with a market share of 1.8% and a total export value of $231.4K across 3 shipments. Their average shipment value of $77.1K is above the market average of $15.2K, suggesting premium or bulk contract pricing.

INVEX HEALTH PRIVATE LIMITED serves 2 named buyers in our database. SENT PHARMA LTD is the dominant customer, accounting for 73.3% of this supplier's tracked business. Top customers include:

• SENT PHARMA LTD — $169.7K across 2 shipments (73.3% of this supplier's total exports)

• SENT PHARMA LIMITED — $61.7K across 1 shipments (26.7% of this supplier's total exports)

Key Insight: INVEX HEALTH PRIVATE LIMITED's per-shipment value of $77.1K is 407% above the market average of $15.2K, consistent with large-order contracts or value-added formulations.

6SP ACCURE LABS PRIVATE LIMITED

SP ACCURE LABS PRIVATE LIMITED is the fifth-largest Melphalan exporter from India, with a market share of 1.5% and a total export value of $192.6K across 30 shipments. Their average shipment value of $6.4K is below the market average of $15.2K, reflecting a high-volume, competitive pricing strategy.

SP ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. XX RXXDY XXLABXXATOX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• XX RXXDY XXLABXXATOX — $192.6K across 30 shipments (100.0% of this supplier's total exports)

Key Insight: SP ACCURE LABS PRIVATE LIMITED operates with high shipment frequency (30 shipments) at a per-shipment value of $6.4K, indicating a broad distribution network with many smaller, regular orders.

1Russia

Russia ranks as the first-largest destination for Melphalan imports from India, with a total trade value of $3.0M across 5 shipments — representing a 23.4% share of all Melphalan exports. The average shipment value of $598.1K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Melphalan importers in Russia: FARMAMONDO LLC is the largest buyer, accounting for 89.6% ($2.7M) of this market's total imports.

• FARMAMONDO LLC — $2.7M (89.6% of Russia's total)

Key Insight: Russia's per-shipment average of $598.1K (3829% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Melphalan imports from India.

Primary Market

Secondary Market

2United Kingdom

United Kingdom ranks as the second-largest destination for Melphalan imports from India, with a total trade value of $2.7M across 78 shipments — representing a 21.3% share of all Melphalan exports. The average shipment value of $34.8K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Melphalan importers in United Kingdom: TILLOMED LABORATORIES LTD is the largest buyer, accounting for 57.4% ($1.6M) of this market's total imports.

• TILLOMED LABORATORIES LTD — $1.6M (57.4% of United Kingdom's total)

• TILLOMED LABORATORIES LIMITED — $987.5K (36.4% of United Kingdom's total)

• TILLOMED LABORATORIES LTD ,,, — $166.1K (6.1% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $34.8K (128% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Melphalan imports from India.

Primary Market

Secondary Market

3Malta

Malta ranks as the third-largest destination for Melphalan imports from India, with a total trade value of $1.2M across 50 shipments — representing a 9.5% share of all Melphalan exports. The average shipment value of $24.2K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Melphalan importers in Malta: TILLOMED MALTA LTD is the largest buyer, accounting for 60.7% ($735.4K) of this market's total imports.

• TILLOMED MALTA LTD — $735.4K (60.7% of Malta's total)

• TILLOMED MALTA LIMITED — $475.7K (39.3% of Malta's total)

Key Insight: Malta's per-shipment average of $24.2K (59% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Malta is a key market for Melphalan imports from India.

Primary Market

Secondary Market

4Canada

Canada ranks as the fourth-largest destination for Melphalan imports from India, with a total trade value of $978.9K across 5 shipments — representing a 7.7% share of all Melphalan exports. The average shipment value of $195.8K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Melphalan importers in Canada: MARCAN PHARMACEUTICALS INC is the largest buyer, accounting for 41.6% ($406.8K) of this market's total imports.

• MARCAN PHARMACEUTICALS INC — $406.8K (41.6% of Canada's total)

• TARO PHARMACEUTICALS INC. — $193.5K (19.8% of Canada's total)

Key Insight: Canada's per-shipment average of $195.8K (1186% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Melphalan imports from India.

Primary Market

Secondary Market

5United States

United States ranks as the fifth-largest destination for Melphalan imports from India, with a total trade value of $968.4K across 0 shipments — representing a 7.6% share of all Melphalan exports. The average shipment value of $968.4K is above the global average of $15.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: United States's per-shipment average of $968.4K (6262% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Melphalan imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Melphalan.
2.Flow Mapping: 153 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 838 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 97 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

838 Verified Shipments

153 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Melphalan

Melphalan

Who Supplies Melphalan? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Melphalan? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Melphalan Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1EMCURE PHARMACEUTICALS LIMITED

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

3GLAND PHARMA LIMITED

4EMCURE PHARMACEUTICALS LTD

5INVEX HEALTH PRIVATE LIMITED

6SP ACCURE LABS PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Melphalan Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Melphalan Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Russia

2United Kingdom

3Malta

4Canada

5United States

People Also Ask — Melphalan Supplier & Trade Network

Melphalan Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology